KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Non-Current Assets (2016 - 2025)

Exact Sciences (EXAS) has disclosed Non-Current Assets for 16 consecutive years, with $4.3 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Assets fell 1.19% to $4.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.2 billion through Dec 2025, down 13.99% year-over-year, with the annual reading at $4.3 billion for FY2025, 1.19% down from the prior year.
  • Non-Current Assets for Q4 2025 was $4.3 billion at Exact Sciences, roughly flat from $4.3 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $5.3 billion in Q2 2022, with the low at $4.3 billion in Q2 2025.
  • Average Non-Current Assets over 5 years is $5.0 billion, with a median of $5.2 billion recorded in 2023.
  • The sharpest move saw Non-Current Assets soared 92.87% in 2021, then decreased 17.84% in 2025.
  • Over 5 years, Non-Current Assets stood at $5.3 billion in 2021, then decreased by 0.27% to $5.2 billion in 2022, then grew by 0.62% to $5.3 billion in 2023, then dropped by 17.44% to $4.4 billion in 2024, then fell by 1.19% to $4.3 billion in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $4.3 billion, $4.3 billion, and $4.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.